{"id":12791,"date":"2014-01-01T00:00:00","date_gmt":"2014-01-01T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/pmn-reprints-by-title\/"},"modified":"2019-02-26T03:32:03","modified_gmt":"2019-02-26T03:32:03","slug":"pmn-reprints-by-title","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/","title":{"rendered":"Pharma Marketing News &#8211; Reprints by Title"},"content":{"rendered":"<hr\/>\n<p> <b>Reprints of Past Articles<\/b><\/p>\n<p>Choose a Reprint by Title                Choose letter: <br \/><a href=\"#A\">A<\/a> | <a href=\"#B\">B<\/a> | <a href=\"#C\">C<\/a> | <a href=\"#D\">D<\/a> | <a href=\"#E\">E<\/a> | <a href=\"#F\">F<\/a> | <a href=\"#G\">G<\/a> | <a href=\"#H\">H<\/a> | <a href=\"#I\">I<\/a> | <a href=\"#J\">J<\/a> | <a href=\"#K\">K<\/a> | <a href=\"#L\">L<\/a> | <a href=\"#M\">M<\/a> | <a href=\"#N\">N<\/a> | <a href=\"#O\">O<\/a> | <a href=\"#P\">P<\/a> | <a href=\"#Q\">Q<\/a> | <a href=\"#R\">R<\/a> | <a href=\"#S\">S<\/a> | <a href=\"#T\">T<\/a> | <a href=\"#U\">U<\/a> | <a href=\"#V\">V<\/a> | <a href=\"#W\">W<\/a> | <a href=\"#Y\">Y<\/a> | <\/p>\n<p><b>A&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn17-article01.html\">The Absolute, Relative, and Incremental ROI of DTC e-Marketing<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn610-article02.htm\">Accomplishing Adherence<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn93-article03.htm\">Accountability for Pharma Content on Social Media Sites<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn47-article04.html\">A Call to Action: A <i>Mea Non Culpa<\/i> by Big Pharma<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1209-article01.htm\">Active Social Media Listening<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn107-article03.htm\">Ad Dollars Follow Eyeballs to Web<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn910-article02.htm\">Ad Execs Not Viewed as Innovative By Americans Says AstraZeneca Survey<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn118-article03.htm\">Adherence: Do We Really Need an App for That?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1012-article01.htm\">Adobe Connect for eDetailing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_106_Upfront.pdf\">Adverse Event Reporting: A Missed Opportunity<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn810-article03.htm\">A Few Things I Learned at FDA&#8217;s Social Media Hearing<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn45-oped.html\">A Good Time Was Had by All<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn64-article03.htm\">Americans Skeptical of Pharma Cause Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1308-article01.htm\">Anecdotal Experience Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn61-article04.html\">An Online Community to Call Our Own<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1016-article06.htm\">Antidepressants: Top Advertised &amp; 3rd Most Commonly Used Rx Drug<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1407-article01.htm\">Anti-DTC Resurgence<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-article05.html\">Applying FDA Marketing Regulations to Internet Promotions<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn63-article03.htm\">Are Pharma Bloggers Biased Against the Industry?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1310-article01.htm\">Are Drug.com Websites &#8220;Fair and Balanced?&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1017-article06.htm\">Are Pharma Reps Important to Docs or Not?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1018-article06.htm\">Are Pharma Sales Reps Service Employees?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn106-article02.htm\">Are Sales Reps as &#8220;Useful&#8221; as PhRMA Wants Us to Believe?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn61-article01.html\">Are Sales Reps Necessary?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn116-article04.htm\">Are Some DTC Print Ads Too Educational and\/or Persuasive?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn104-article03.htm\">AstraZeneca Hosts First-Ever Twitter Chat<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn69-Oct07-oped.htm\">Awards. What Are They Good For?<\/a><\/li>\n<p\/> <\/ul>\n<p><b>B&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn121-article02.htm\">Bad, Devalued, Distrusted &amp; Defensive Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn210-article04.html\">Balancing Idealistic vs. Realistic CRM Processes<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1401-article03.htm\">2014: A Banging Year for Drug Approvals, A Wimpy Year for Enforcement\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn510-oped.html\">Betting the Pharm<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn32-article05.html\">Beyond DTC: Consumer Relationship Satisfaction<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn32-article02.html\">Beyond Patient Education: Influencing Behavior Change<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn44-article03.html\">Beyond the eDetail: Evolving to Educate<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn112-article01.htm\">Big Bad Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1015-article04.htm\">The Big C in the Big Apple<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn66-article02.htm\">Big Pharma Sales Analytics for the Rest of Us<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn55-article02.html\">Biotech DTC: Business Not As Usual<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1309-article02.htm\">BI Receives Pharmaguy Social Media Pioneer Award<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-oped.html\">Blogging My Way Into 2005!<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn411-article01.html\">Blogs and the Pharmaceutical Industry<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1014-article01.htm\">Boehringer vs Facebook Social Media Socialism<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn52-article03.html\">Branded Physician Education: How to Integrate Promotion and Education<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn28-article03.html\">Branding Internally: Think Brand, Not Product<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn59-article03.html\">The Brand Marketing Mix<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1502-article03.htm\">Brave New World of Off-Label Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn103-article02.htm\">Breaking the 140-character Limit of Twitter<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1013-article01.htm\">British Pharma Digital Update<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1011-article04.htm\">The British Pharmaceutical Industry Issues Social Media Guidance for Adverse Event Reporting<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn107-article05.htm\">Brits Beat FDA &amp; PhRMA: Issue Social Media Guidance for Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn74-article02.htm\">Building a Blockbuster<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn92-article02.htm\">Building the &#8220;New&#8221; Pharma Physician Marketing Model<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn82-article02.htm\">Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn77-article02.htm\">Building Power Sales Messages<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn53-oped.html\">Buzz &#8216;n Blog Marketing<\/a>\n<p\/><\/li>\n<p> <\/a><\/li>\n<\/ul>\n<p><b>C&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn37-article01.html\">California&#8217;s Physician Prescribing Act: A History of Twists and Turns <\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article01.html\">Can Health Web Sites Improve Compliance?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn99-article03.htm\">Capturing &amp; Reporting HCP-Related Meeting Spending<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn48-article01.html\">cDetailing: Addressing the Consumer Education Gap<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1406-article02.htm\">Celebrities + Social Media<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1019-article02.htm\">Certain Physician-Drug Industry Relationships Have Declined Dramatically<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn109-article02.htm\">Challenges of Regulating Mobile Medical Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn95-article01.htm\">The Changing Pharma Commercial Model in 2010 and Beyond<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1018-article03.htm\">The Changing Pharma eDetailing Landscape<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn67-article03.htm\">The Changing Landscape of Physician Interactions<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn710-article01.htm\">The Changing Policy Landscape: Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn107-article01.htm\">The Changing Role of Pharma Sales Reps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn55-article01.html\">The Changing World of MSLs: Determining Value<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1019-article04.htm\">Checking Under the Hood of Pharma Mobile Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn71-article05.htm\">Cholesterol Drug Users Discuss Their Medication<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1012-article03.htm\">Citizen Petition Likely to Delay FDA Social Media Guidance<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn73-article04.htm\">Closed Loop Marketing<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn97-article03.htm\">Closed-Loop Patient Education<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn69-article01.htm\">Collaborating with Online Physician Communities<\/a>        <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1206-article02.htm\">The Comeback of CME without Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn112-article04.htm\">The Coming Pharma Digital Depression<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn73-article01.htm\">The Coming Pharma Marketing Recession<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn54-article01.html\">Communicating Risk: Let the Dialog Begin<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-article01.html\">Compliance with (Some) New ACCME Rules Not So Easy<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn510-article01.html\">Congress vs. Pharma: Trouble Ahead?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn810-article01.htm\">Consequences of Direct-to-Consumer Advertising<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn109-article03.htm\">Consequences of eDetailing Technology<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1402-article01.htm\">The Consumer Brief Summary: FDA&#8217;s New Thinking Regarding Risk Communication<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn23-article02.html\">Consumer Use of the Internet for Health: Whose Numbers Do You Believe?<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn31-article03.html\">Controlling Your Brand&#8217;s Switch Destiny<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn91-article02.htm\">Corporate Reputation in the New Media World<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn310-oped.html\">Corporate &#8220;Moral Values&#8221; Anyone?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-article06.html\">Cost-Cutting Strategies for the Pharma Industry <\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn56-oped.html\">Could Chill Kill CME?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn310-article02.html\">Creating a Successful DTC Campaign on the Inside<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn76-article02.htm\">Creating the Most Effective Sales Calls<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn37-article02.html\">A Crisis in Professional Detailing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn710-article03.htm\">Critical: What Daschle Plans to Do About the Healthcare Crisis<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn117-article02.htm\">Crowd Sourced Creative Commons Drug Information<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn77-article03.htm\">Current Issues and Future Prospects for Sales Force Effectiveness<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1502-article02.htm\">Cute &amp; Creepy DTC Drug Ad Mascots<\/a><\/li>\n<p\/> <\/ul>\n<p><b>D&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn95-article03.htm\">Data Mining in the Deep, Dark Social Networks of Patients<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_102_Upfront.pdf\">Deal with Lack of Regulations by Developing Best Practices<\/a> (pdf) <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1018-article05.htm\">Deconstructing Pitts&#8217; Guiding Principles for Pharma Social Media<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1403-article01.htm\">The Debut of the Chief Patient Officer: A Passing Fad or Transformative?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn84-article01.htm\">Developing Guidelines for Pharma&#8217;s Use of the Internet &amp; Social Media<\/a>: A Call for a Public Hearing at FDA  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn210-article01.html\">Developing Win-Win Key Opinion Leader Relationships<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1018-article01.htm\">The Digital Life of Doctors<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1012-article02.htm\">The Digital Health Coalition<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn98-article02.htm\">Digital Pharma Is Alive and Well in Europe!\/A&gt;\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn108-article05.htm\">Digitally-Feeble Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1501-article03.htm\">Digitally Savvy Women Pharma Pioneers<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn51-article02.html\">Direct to Physician Telemarketing and Sales<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn54-oped.html\">Disease Mongering<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn63-article01.htm\">Disease Mongering: When Is the Line Crossed?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn76-article03.htm\">Diversity in the Life Sciences<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn610-NovDec07-oped.htm\">Diversity in Pharma<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn113-article04.htm\">Do Drug Copay Coupons Drive Up Healthcare Costs?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn411-article02.html\">DocCheck: Das Portal<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn42-article05.html\">Does the FDA Need to be Overhauled?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn55-oped.html\">Doing a Good Job but Still Not Trusted!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1302-article02.htm\">Do TV DTC Ads Overstate Rx Drug Risks?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1016-article03.htm\">Double Dip in DTC Ad Spend!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1308-article02.htm\">Drug Industry v. FDA Re: Twitter &amp; Google Adwords<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn39-article05.html\">Drug Reimportation Survey Results<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn25-article04.html\">Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article07.html\">Drug Prices, Declining Profits Top Issues for 2005<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-article04.html\">Drug Risk Survey Results<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1403-article02.htm\">DTC Ad Spending Rises From the Grave: Pfizer Leads the Ghoulish Pack<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn68-Sep07-oped.htm\">DTC, for Better or Worse, is Here to Stay<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn42-article03.html\">DTC in 2005: Can You Teach Old Dogs New Tricks?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1310-article02.htm\">DTC Promotion Directed at Adolescents<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn410-article01.html\">DTC Pros and Cons Presented at FDA Hearing<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn74-article01.htm\">DTC Risk Communication<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn71-Jan08-oped.htm\">DTC User Fees Go PDUffft!<\/a>\n<p\/><\/li>\n<p> <\/a><\/li>\n<\/ul>\n<p><b>E&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn49-article01.html\">eDetailing: Yesterday, Today and Tomorrow<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn51-oped.html\">The End of DTC as We Have Known It<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn44-article01.html\">E-mail Marketing Best Practices for Pharma<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn34-article04.html\">Emotions, Focus and Storytelling: How Cialis is Challenging Viagra<\/a>              <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn24-article03.html\">e-Marketing at the Point of Care<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-article03.html\">Effective Pharma Adherence Programs Start With The Patient<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn53-article03.html\">Effective Physician Marketing at Medical Meeting Exhibits<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn59-article01.html\">e-Inertia Plagues the Pharma Industry<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn84-article02.htm\">The Empowered Patient<\/a>: What It Means for Pharma Marketers  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn81-article02.htm\">The ePharma Pioneer Club\u2122: Convincing Pharma Marketers to Engage in &#8220;e&#8221;<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn95-article02.htm\">ePrints NRx for Physician Detailing<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn54-article04.html\">The Electronic Formulary Will Change the Equation<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1305-article02.htm\">The Emerging Virtual Medical Conference<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn57-oped.html\">Engagement<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn25-article03.html\">Ethical Online Practices Build Consumer Trust<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn35-article02.html\">European Compliance Not Only Possible, But Leading Edge<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn53-article01.html\">The European eMarketing Scene: Desperately Seeking Strategy<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn53-article02.html\">European Online Marketing Survey Results<\/a>       <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1209-article02.htm\">Evaluating DTC TV Drug Ads<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1016-article01.htm\">Everything You Need to Know About Mobile Platforms<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn105-article02.htm\">Evidence-Based Pharma Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn28-article02.html\">Evolve Your Brand into a Relationship with Consumers and Physicians<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn48-article02.html\">The Evolving Impact of Anti-Spam Legislation on Online Marketers<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn115-article04.htm\">The Evolving Pharma-Physician Relationship<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn62-article01.html\">The Expanding Pharma Blogosphere<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn115-article01.htm\">Exploring the 2.0 Doctor-Patient Relationship<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn97-article02.htm\">Eyes on the Adherence Prize\/A&gt;\n<p\/><\/a><\/li>\n<\/ul>\n<p><b>F&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article02.html\">Facilitating Physician Access and Education Through Online Conferencing<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1011-article02.htm\">Fair Social Media Practice Principles<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn58-article02.html\">Fast Start to Customized ePromotion and eLearning Physician Programs<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_93_UpFront.pdf\">FDA Can Relax. I Did All the Work for Them!<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn32-article03.html\">FDA Draft Guidance for Print DTCA: Less than Feared<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn86-article03.htm\">FDA Draft Guidance on Risk<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1010-article03.htm\">FDA Drops Social Media from Its Guidance Agenda<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn81-article03.htm\">FDA Finalizes Guidance on Distribution of Reprints<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn111-article02.htm\">FDA Guidance: Responding to Unsolicited Requests for Off-Label Information<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn106-article03.htm\">FDA Issues Long-Awaited Guidance for Mobile Medical Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn103-article03.htm\">FDA&#8217;s Abrams Spends 4 Minutes on Social Media!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn72-article01.htm\">FDA&#8217;s Good Reprint Practices Guidance<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1306-article02.htm\">FDA Opens Window for Pharma to Correct Misinformation Online<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1301-article04.htm\">FDA Publishes First Piece of Long-Awaited Social Media Guidance<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1306-article01.htm\">FDA Sets Up a Roadblock for Branded Rx Promotional Tweets<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn83-article03.htm\">FDA&#8217;s Use of Social Media: Peanuts Today, Drugs Tomorrow!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn108-article04.htm\">FDA to Test New Standard for Easy to Understand Drug Labels<\/a><\/li>\n<li><a href=\"http:\/\/pharmamkting.blogspot.com\/2011\/05\/how-fda-in-cahoots-with-doj-brought.html\">FDA v. Google &amp; Those 14 Infamous Warning Letters<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn111-article03.htm\">FDA Social Media Guidelines May Be Moot<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_89_UpFront.pdf\">Fear and Loathing in Washington, DC<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1011-article01.htm\">Finding the Consumer Within the Patient<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn31-article02.html\">Finding the &#8220;Right Stuff&#8221; to Revitalize Sales Productivity<\/a> <\/li>\n<li><a href=\"http:\/\/pharmamkting.blogspot.com\/2011\/06\/first-fda-social-media-guidance-to.html\">First FDA Social Media Guidance to Address Responding to &#8220;Unsolicited Requests&#8221; for Off-label Information<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn113-article02.htm\">Focus on Drug Safety Communication &amp; TV DTC Advertising<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1309-article02.htm\">A Formula for Patient-Centric mHealth Apps\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1013-article02.htm\">Four Useful Lessons Pharma Can Learn from the Pfizer Facebook Hack<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn79-article01.htm\">Free Drug Samples: The Sales Rep&#8217;s Last Great Hope?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn52-article01.html\">Free Gifts to Physicians: What&#8217;s the Big Deal?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn56-article03.html\">Free Prescription Drug Cards<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn85-article04.htm\">From Nalty to &#8220;Nalts&#8221;<\/a>: The Transformation of a Pharma Marketing Director into a &#8220;Viral Video Genius&#8221; <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn66-article04.htm\">From Science to CEO: The Scientific Path to Corporate Leadership<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn211-article03.html\">The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn34-oped.html\">The Future of Big Pharma<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn81-article01.htm\">The Future of DTC Advertising: Is a Perfect Storm Brewing?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn29-article04.html\">The Future of eDetailing<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1110-article03.htm\">The Future of Pharma Marketing is Mobile, Unless &#8230;<\/a><\/li>\n<p\/><\/a><\/li>\n<\/ul>\n<p><b>G&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn117-article04.htm\">Gamification<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn411-article03.html\">Generation Rx: A History and Critique of Pharma &#8220;Tribal Marketing&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1204-article02.htm\">Get Social, #GetFit and Get Healthy<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn98-article03.htm\">Getting Market Research Right in Emerging Markets<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn102-article02.htm\">Getting Market Research Right in India &amp; China<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn99-article02.htm\">Getting Market Research Right in the Middle East\/A&gt;\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-oped.html\">Give Docs What They Want<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn410-article04.html\">Global Digital Asset Brand Management<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn78-article03.htm\">Global Pharma Competitive Intelligence<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn62-oped.htm\">God Bless R&amp;D, but Marketers May Go to Hell!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn103-article01.htm\">Good Promotion Practices Alliance<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn104-article02.htm\">Google&#8217;s OneBox Drug &#8220;Ads&#8221; Steal Clicks Away from Rx Brands<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn66-article03.htm\">Got Game? Online Pharma Advergaming<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn44-article04.html\">Growing Pharmaceutical Sales Utilizing Six Sigma and Lean<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn103-article05.htm\">GSK&#8217;s U.S. Sales Reps &#8220;Europeanized&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn410-article03.html\">GSK Strikes Back with a Grassroots Campaign<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn74-article03.htm\">Guerilla Pharma Marketing<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn211-article05.html\">Guidelines for Off-label Communications<\/a>\n<p\/><\/li>\n<p> <\/a><\/li>\n<\/ul>\n<p><b>H&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn52-article04.html\">Hard Sell: The Evolution of a Generation X Salesman<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn21-oped.html\">Has DTC Spending Peaked?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn104-article01.htm\">HCP Marketing Beyond the Physician: Plugging Into NPs and PAs<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_91_UpFront.pdf\">Healthcare Communications vs. Pharma Marketing<\/a> (pdf)         <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1203-article01.htm\">Help Doctors Educate Patients About Their Condition &amp; Treatment<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn72-article02.htm\">Helping Pharma eMarketing &#8220;Grow up&#8221;<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn113-article01.htm\">HealthPrize Teams Up with RealAge to Improve Adherence<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn116-article02.htm\">Here Come the Pharma Wikipedians<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn75-article02.htm\">High Impact Content in Support of Rx Brands<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1110-article01.htm\">How is the iPad an Effective Delivery Platform for Medical Sales Professionals?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn64-article01.htm\">How Readable, Credible &amp; Useful are Pharma Blogs?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1407-article02.htm\">How to Achieve Digital Pharma Marketing Results<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn75-article03.htm\">How to Get Your Message In Front of Pharma Brand Managers<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1306-article03.htm\">How to Host a Successful Pharma TweetChat<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn94-article02.htm\">How to Manage the Online Conversation<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1016-article02.htm\">How to Score With Women (as a Marketer) via Social Media<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-article03.html\">How to Sell a Drug Before it is Approved <\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn86-article02.htm\">How Should Pharma Engage in Social Networks?<\/a>: Thoughts on Best Practices            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn81-article04.htm\">The Hypocrisy of Healthcare Marketing Restrictions: Stand Up for Healthcare Marketing Free Speech<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>I&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn73-Mar08-oped.htm\">I&#8217;m All a Twitter Over Twitter<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn29-article02.html\">The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn108-article02.htm\">Implications of Facebook&#8217;s Page Commenting Changes<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-article02.html\">Increase Prescription Sales with Smart Tools<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn77-article04.htm\">India&#8217;s Booming Pharmaceutical Market<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn93-article01.htm\">Industry and Consumer Advocates Square Off Regarding Social Media<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1015-article03.htm\">In Memory of Steve Jobs Will Novartis Sales Reps Really Embrace iPads?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn63-article02.htm\">Innerstate: The First Disease Awareness Documentary Film<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn211-article06.html\">Integrating Compliance into Commercial Practices<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn23-article01.html\">Integrating Online &amp; Offline Marketing: Challenges for Pharma<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn98-article01.htm\">Integration of Custom Media into the Marketing Mix<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn34-article01.html\">Intelligent Online Sampling Strategies<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn34-article02.html\">The Internet and CME<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn59-oped.html\">Interpretation of Ads<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn96-article01.htm\">The iPad as a Pharma Marketing Platform<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn118-article01.htm\">The iPad in the Doctor&#8217;s Office<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn71-article04.htm\">Is It Time to End Industry Sponsored CME?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn119-article03.htm\">Is Online Pharma Advertising ROI Scalable?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn19-article01.html\">Is Pharma Ready for HIPAA?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn45-article05.html\">Is Pharma Marketing a Lot of BS?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn119-article01.htm\">Is Your Marketing Head in the Cloud?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn310-article04.html\">Is Your Product Ready for Consumers?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn26-oped.html\">It&#8217;s All About Education<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn48-oped.html\">It&#8217;s the Science, Stupid!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn111-article04.htm\">Is There a Cure for Mediocre Pharma Mobile Apps?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1016-article04.htm\">Is There an Upward Career Path for Pharma Social Media Pioneers?<\/a><\/li>\n<p\/> <\/ul>\n<p><b>J&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn67-Aug07-oped.htm\">J&amp;J&#8217;s PR Hindenburg Disaster!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn72-Feb08-oped.htm\">Jarvik: A Modern DTC Tragedy<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1017-article02.htm\">Johnson &amp; Johnson&#8217;s ennTV<\/a><\/li>\n<p\/> <\/ul>\n<p><b>K&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn32-article01.html\">Key Issues Facing DTC Marketers in 2004<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1403-article03.htm\">A KOL by Any Other Name: Too Toxic for Everyday Use, or Still the Best Term to Use?<\/a><\/li>\n<p\/> <\/ul>\n<p><b>L&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_88_UpFront.pdf\">Let&#8217;s Respond to FDA&#8217;s Questions Regarding Its Regulation of Social Media<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-article04.html\">Leverage Health Beliefs to Develop Effective Online Compliance Programs<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1301-article03.htm\">Leveraging Infographics and Search for Better Health Communications<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1405-article02.htm\">Leveraging Multi-Channel Infographics for Patient Support<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-article03.html\">Limbic Market Research: Plumbing the Subconscious Motivators of Physicians<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1018-article04.htm\">Limiting Bias in Commercially Supported CME<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn114-article03.htm\">Lipitor Holds Key to DTC Ad Spending in 2012<\/a><\/li>\n<p\/> <\/ul>\n<p><b>M&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn119-article02.htm\">Making Sense of Multichannel Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn49-article02.html\">Managing Cross Boundary Issues<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article05.html\">Managing Medical Science Liaisons From Afar<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn211-article02.html\">Managing Privacy Risks in Your Commercial Practices<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn54-article03.html\">Managing Reprints for Better Clinical Support of Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn610-article01.htm\">Mapping New Paths through the DTC Marketing Mix Maze<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn45-article03.html\">Marketing in the Post-Vioxx Era<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn47-article02.html\">Marketing the Pharma Industry: The Empire Strikes Back<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn43-article01.html\">Marketing&#8217;s Role in Limiting Physician Access and What to Do About It <\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn34-article05.html\">Maximizing the DTC Message: Healthcare Businesswomen&#8217;s Association Members Evaluate DTC Marketing<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn65-article01.htm\">Measuring an Intangible: Medical Science Liaison Metrics Consensus<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn79-article03.htm\">Measuring &amp; Communicating eSuccess: Strategy First, YouTube Later&#8230; Maybe<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn44-article02.html\">Measuring Marketing Strategy<\/a>    <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn68-article03.htm\">Measuring Consumer Sentiment About Prescription Drugs<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn78-article02.htm\">Medical Device Marketing<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-article02.html\">Medical Science Liaisons: Working between Two Worlds <\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn610-article03.htm\">Medical Transcript Advertising<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn54-article02.html\">Merit of CHC Petition to FDA<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn67-article01.htm\">Merck Rejiggers Its Marketing Mix<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn48-article04.html\">Midwestern eMarketing Values<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn107-article02.htm\">Mining Mobile Health App User Data<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1207-article02.htm\">Mobile Apps Track Sunshine Payments<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1405-article03.htm\">The Mobile Health Library\u2122<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1204-article01.htm\">Mobile Medical App Guidance &amp; Beyond!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn49-article04.html\">Mobile Medical Reference: An Effective Door Opener for Sales Reps<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1110-article02.htm\">Mobile Optimization Offers Better ROI Than Mobile Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn65-article03.htm\">Mobile Pharma Marketing: What&#8217;s the 411?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn112-article02.htm\">Mobile Regulatory Fears: PhRMA Raises an Alarm<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn94-article03.htm\">Moderation Best Practices for Pharma Social Networks<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn65-May07-oped.htm\">Moore: Please Don&#8217;t Ignore Us Pharma Bloggers<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1011-article03.htm\">Most Credible Bad Ad Complaints are Submitted by Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article04.html\">Motivating &amp; Retaining The MSL: What Makes MSLs Tick<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn75-article01.htm\">Moving the Needle on Adherence<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article03.html\">MSL Role in Educational Development<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn57-article04.html\">MSL Roles &amp; Goals<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn117-article01.htm\">Multichannel Marketing &amp; Medical Reprints<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn117-article03.htm\">Multichannel Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn65-article04.htm\">Murky Physician Marketing and Education Practices<\/a><\/li>\n<p\/> <\/ul>\n<p><b>N&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1014-article02.htm\">New Big Pharma Economies of Scale<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn108-article03.htm\">A New Estimate of Drug Development Cost<\/a><\/li>\n<li><a href=\"http:\/\/www.forums.pharma-mkting.com\/showthread.php?t=46686\">New Facebook Policy &#8220;Kind of Hurts&#8221; Pharma Marketers<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn910-article01.htm\">New Media Privacy Issues &amp; Online Health Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn85-article03.htm\">The New PhRMA Code and Beyond<\/a>: Federal &amp; State Laws are Eclipsing Self-Regulation<\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn83-article04.htm\">New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn82-article03.htm\">The New Rules of Marketing &amp; PR: Book Review and Insights for Pharma<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn610-article05.htm\">New Social Media Regulatory Framework<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-article06.html\">The New Written Prescription: Leveraging Technology to Measure Change in Physician Behavior as it Occurs<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1401-article02.htm\">2015 New Year&#8217;s Resolutions<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1402-article02.htm\">The Next FDA Commissioner Will Be&#8230;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn39-article04.html\">No More Free Lunch in California?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn310-article03.html\">A Novel Approach to Communicating with Physicians<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn111-article01.htm\">Novo Nordisk Defends Choice of Paula Deen as Diabetes Spokesperson<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn58-oped.html\">Numbers<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>O&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn78-article01.htm\">Obama v. McCain Survey Results<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn66-Jun07-oped.htm\">One&#8230;uh, Two Small Steps for Pharmaco Blogging!<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn21-article03.html\">Online and Offline Professional and Consumer Marketing<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn26-article01.html\">Online CME &#8211; A Glass Half-Full or Half-Empty?<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn65-article02.htm\">Optimizing Brand Equity: Pre-Launch through Patent Expiry and Beyond!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn79-article02.htm\">Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn59-article02.html\">Optimizing DTC Performance<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn29-article03.html\">Optimizing eDetailing ROI<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1014-article03.htm\">Orphan Drugs Now &#8220;Where the Money Is,&#8221; Says Willie Sutton&#8217;s Ghost<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn27-article02.html\">Out-of-the-Box Marketing: Will It Work for Pharma?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn93-article02.htm\">Overcoming Space Limitations in Social Media<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn87-article01.htm\">Owning the Prescription Pad<\/a>: Driving Brand Decisions in a Multi-Influence World\n<p\/><\/li>\n<\/ul>\n<p><b>P&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn53-article04.html\">Paid Inclusion: Too Hot for Pharma Marketing?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1307-article01.htm\">Patient Activists Demand Higher Quality Mobile Health Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn710-article02.htm\">Patient Assistance Program Rankings: Going Beyond Sales Force Effectiveness to Customer Experience Satisfaction<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1402-article03.htm\">Patient Centricity, Transparency, &amp; Pharma&#8217;s Reputation: Getting Beyond Lip Service<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn27-article01.html\">Patient-Level Data: A New Level of Analysis<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn48-article03.html\">Patient Detailing at the Point of Care<\/a>           <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1307-article02.htm\">Patient Storytelling Marketing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1404-article03.htm\">The Patients Included Initiative &amp; Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn18-article01.html\">Personalized e-Marketing &#8211; How can you create and profit from a customer&#8217;s lifetime experience?<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn55-article03.html\">Peter Rost: Whistle Blower, Pharma Blogger, ???<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1018-article02.htm\">Pfizer Battles to Protect Lipitor Cash Cow<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn51-article03.html\">Pfizer France: Viva la SFE Difference!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1017-article03.htm\">Pfizer&#8217;s Chapstick Slapstick Facebook Fiasco<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn910-article03.htm\">FREE! Pfizer&#8217;s SamplesDirect eSampling Program<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn116-article01.htm\">Pfizer&#8217;s Short-lived LIPITOR Branded Mobile App<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1012-article05.htm\">Pfizer, Show Us Your Social Media &#8220;Playbook&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn115-article02.htm\">Pfizer Throws in the Lipitor Marketing Towel<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn91-article03.htm\">Pharma Begins to Reveal Payments to Physicians<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-article06.html\">Pharma BloggoSphere Update<\/a>        <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1205-article01.htm\">Pharma C-Suite Social Media Dummies<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_99_UpFront.pdf\">Pharma Collaboration with Online Patient Opinion Leaders<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1301-article02.htm\">Pharma Content Marketing Strategies<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1302-article03.htm\">Pharma Brand Personality Traits<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_95_UpFront.pdf\">Pharma Crisis Communications in the Fast-paced World of Twitter et al<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn36-oped.html\">Pharma eMarketing: A Level Playing Field or a Killing Field?<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1013-article04.htm\">Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1304-article01.htm\">Pharma Finds Little to Like in Recent FDA Social Media Guidance<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1203-article02.htm\">Pharma is Overcoming Social Media Hurdles<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn86-article01.htm\">Pharma Marketers Dive Deeper Into Social Media<\/a>: The Good, the Bad, &amp; the Ugly Case Studies  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn410-oped.html\">Pharma Marketing Blog a &#8220;Must Read&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1404-article01.htm\">Pharma Marketing Buzzwords<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1208-article02.htm\">Pharma Marketing Ethics &amp; Corporate Reputation Compendium<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn71-article02.htm\">Pharma Marketing Network 2007 Report<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn24-article02.html\">Pharma Marketing Network Survey Results<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn68-article04.htm\">Pharma Marketing Stuck in Web 1.5<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn610-article04.htm\">Pharma Marketing Roundtable &#8211; Members Only!<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn52-oped.html\">Pharma McCarthyism<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn59-article04.html\">Pharma Online Spending<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn118-article02.htm\">Pharma Paid Celebrity Best Practices<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn97-article01.htm\">Pharma, Physicians, and Sermo<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1404-article02.htm\">PharmaPhobia &amp; What to Do About It<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1305-article01.htm\">Pharma Promotional Spending in 2013<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn115-article03.htm\">Pharma Responds to FDA&#8217;s Draft DTC Guidelines<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn109-article01.htm\">Pharma SmartPhone\/Tablet Apps: Is There a Regulation for That?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1010-article02.htm\">A Pharma Social Media Conspiracy Theory: FDA, DOJ vs. Google<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1207-article03.htm\">Pharma and Social Media &#8211; Comfy Bedfellows<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn88-article02.htm\">Pharma-Sponsored Medical Ghostwriting<\/a>: What the Ghosts Have to Say About It<\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn106-article01.htm\">Pharma TeleWeb e-Detailing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn51-article01.html\">Pharma Trends to Watch in 2006<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1017-article05.htm\">Pharma Turns Up Heat to Unchill Off-Label &#8220;Free Speech&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn105-article01.htm\">Pharma Twitter Pioneers Recognized<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1017-article04.htm\">Pharma YouTube Patient Videos Lack Transparency<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_910_UpFront.pdf\">Pharma&#8217;s 2010 Christmas Wish List for Santa<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn83-article01.htm\">Pharma&#8217;s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the Public&#8217;s Trust<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn58-article03.html\">Pharma&#8217;s Black Knight Confesses All!<\/a>       <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn211-article01.html\">Pharma&#8217;s Confidence Crisis: A Call for a New Marketing Paradigm?<\/a>                    <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1206-article01.htm\">Pharma&#8217;s Digital Media Adoption Curve<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn810-article04.htm\">Pharma&#8217;s Image Conundrum: Building Brand Loyalty and Consumer Confidence<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1014-article04.htm\">Pharma&#8217;s Physician Bailout<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn510-article02.html\">Pharma&#8217;s Plodding Approach to eMarketing<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn73-article05.htm\">Pharma&#8217;s Social Media Marketing Readiness Score<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn92-article03.htm\">Pharma&#8217;s Social Media Working Group<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1406-article01.htm\">Pharma&#8217;s Use of Medical Conference Twitter Hashtags<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn69-article04.htm\">Pharmaceutical Competitive Intelligence<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn12-article01.html\">Pharmaceutical Compliance with Fair Information Practice Principles<\/a>    <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn89-article02.htm\">Pharmaceutical Market Access 2010<\/a>: Strategic Developments Impacting the US, EU, and Emerging Markets  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn25-article01.html\">Pharmaceutical Marketing in Texas: look out for state privacy laws!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn96-article03.htm\">The Pharmaguy Next Door<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn121-article01.htm\">Pharmaguy&#8217;s Pharma Predictions<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1208-article01.htm\">Pharmaguy&#8217;s Social Media Compendium<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1010-article01.htm\">The Pharmaguy Social Media Timeline\u2122: Volume 1<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1302-article01.htm\">The Pharmaguy Social Media Timeline\u2122: Volume 2<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn88-article03.htm\">Pharmaguy&#8217;s Twitter Followers<\/a>: What Do They Want and How Is It Relevant to You? <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn58-article04.html\">Pharmacy TeleStocking<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn107-article04.htm\">The Phil Mickelson Enbrel Campaign<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn24-article01.html\">PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn211-article04.html\">PhRMA Code Succeeding So Far<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1015-article05.htm\">PhRMA Masters the Art of &#8220;Proofiness!&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn77-article01.htm\">PhRMA&#8217;s New Code on Interactions with Healthcare Professionals<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1309-article01.htm\">PhRMA Tells FDA How It Wants to Correct &#8220;Misinformation&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn39-article01.html\">Physician Adoption and Use of Technology at the Point of Care<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn108-article01.htm\">Physicians Favor Brands With a Compelling Adherence Program<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn99-article01.htm\">Physician-Generated Content on Social Media Sites<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn57-article03.html\">Physician Meetings: Education Works Both Ways<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1015-article01.htm\">Physician Participation in Peer-to-Peer Social Media Sites<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn109-article04.htm\">Physicians Are Concerned That Pharma Supported CME is Biased, But &#8230;<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1207-article01.htm\">Physicians Under Pharma&#8217;s Influence<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1209-article03.htm\">Physician Value Index\u2122<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1019-article03.htm\">Politics Vs. Science in the Plan B Decision<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1406-article03.htm\">The Power of Patient Input<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1015-article02.htm\">The Pozen Digital Advisory Board<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn57-article01.htm\">PR: Advertising by Other Means<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1013-article03.htm\">PR &amp; Interactive Agencies Vie for Pharma Social Media Campaign Crumbs<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn91-article01.htm\">Predicting the Future of the Drug Industry<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn410-article02.html\">Predictive Physician Marketing<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn710-Dec08-upfront.htm\">Prepare or Die!<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn72-article04.htm\">Prescription Drugs and the Health 2.0 Opportunity<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1308-article02.htm\">Presenting &#8220;New Risk Information&#8221; About Drugs to HCPs<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn37-oped.html\">The Price of Drugs<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn64-article05.htm\">A Primer on Pharma Employee Blogging<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn58-article01.html\">Print DTC: How Does It Measure Up?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn25-article02.html\">Proactive e-Marketing Plan<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn25-article05.html\">Product Branding, e-Marketing May Be Underutilized<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn17-oped.html\">Product Web Sites: Are They Worth It?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn45-article01.html\">A Proposal for a Drug Risk Advisory System<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1019-article01.htm\">Proposed Rules for Physician Payment Sunshine Act<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-article02.html\">Protecting Your Brand with Anti-Counterfeiting Solutions<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn85-article01.htm\">Protection from Brand Infection<\/a>: Marketers Must Take Control of Their Brands, Especially Online  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn26-article02.html\">Provider\/Pharmaceutical Partnerships &#8211; Are They Possible Without Conflict of Interest?<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn35-oped.html\">Pushing the Envelope is Bad for DTC<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn210-article02.html\">Putting the Customer Back in Customer Relationship Management<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>Q&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn22-article01.html\">Quality of Pharma-sponsored Health Information on the Internet<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>R&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn85-article02.htm\">Ramifications of FDA Regulatory Actions<\/a>: Helping FDA Find a New Media Regulatory Pathway  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn69-article03.htm\">Re-Designing the Pharma Sales Force<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn94-article01.htm\">Real Patient Testimonials<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn105-article03.htm\">Real Patients Star in Pharma Youtube Videos<\/a><\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1206-article03.htm\">Redeemed &#8220;Sinners&#8221; as Pharma Spokespeople<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn710-article04.htm\">Reforming the FDA: It All Starts with a New Commissioner!<\/a>        <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1202-article01.htm\">Reigning in the &#8220;Wild West&#8221; of Mobile Health Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn61-article02.html\">Reinventing the Sales Model<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn57-article02.html\">Relationship Marketing via eNutrition<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn42-article02.html\">Relationship Marketing Program Management for Pharmaceutical Marketers<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn210-oped.html\">Relationships<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn69-article02.htm\">Rep Access Programs<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn84-article04.htm\">Report from the Social Pharmer &#8220;Unconference&#8221;<\/a>: Sowing Seeds of Social Media Change? <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn74-article04.htm\">Reporting Gifts to Physicians<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn26-article04.html\">Responding to the Challenges of Evolving Regulation<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn47-oped.html\">Restrict DTC, but Extend the Patent for New Drugs<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn21-article02.html\">Results from FDA Physician Survey on DTC Advertising<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn45-article04.html\">Return on CME: Are Pharma Companies Getting Desired Outcomes?<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn35-article03.html\">The Revitalized Brand: Creating a New Brand Image from an Old Product<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn89-article03.htm\">Risk Mitigation and Its Impact on Pharma Marketing<\/a>: Appropriate Use Benefits After Launch <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1303-article02.htm\">Right &amp; Wrong Ways for Pharma to Correct Misinformation on Wikipedia<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn39-article02.html\">The Role of Tablet PCs in Pharma Sales and Marketing<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>S&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn510-article03.html\">Sales Effectiveness Meets eMarketing<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn82-article04.htm\">Sales Force Effectiveness Metrics: More Important Than Ever in a Tough Market<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn410-article05.html\">Sales Rep Assessment: Shoot the Messenger, the Message, or Both?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn61-article03.html\">Sales Reps Debate Their Value<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn114-article02.htm\">Sanofi Launches Diabetapedia<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn119-article04.htm\">Sanofi US Diabetes Team Wins 3rd Annual Pharmaguy Social Media Pioneer Award<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-article01.html\">Scenarios on the Future of Pharma Marketing: No Time Like the Present to Think the Unthinkable<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn810-article02.htm\">Search Advertising Options for Pharma<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn35-article01.html\">Searching for Answers on Search Engine Marketing?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn44-oped.html\">Separation of Church and State<\/a>         <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1202-article02.htm\">Self-Regulation as a Collective Blocking Strategy<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn63-oped.htm\">Should Bloggers Dine at Pharma&#8217;s Table?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn66-article01.htm\">SiCKO is Boffo but Not Anti-Pharmaco Per Se<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn56-article02.html\">Slides: The Currency of Communication<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn87-article02.htm\">Social Communications in Healthcare<\/a>: Summary of Roundtable Discussions <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn89-article01.htm\">Social Media Adverse Event Reporting Safe Harbors<\/a>: It&#8217;s Time for FDA to Open Up the Internet to Rx Advertising Like It Did with TV!  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_98_UpFront.pdf\">Social Media and the Limitations of Disease Awareness Campaigns<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_84_UpFront.pdf\">Social Media&#8211;Opportunity or Nightmare?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_87_UpFront.pdf\">Social Media &amp; the Truncated News Pyramid<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn96-article02.htm\">Social Media Leaders Wanted<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1303-article01.htm\">Social Media, Latent Spokespersons &amp; Native Advertising<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn62-article03.html\">Social Network Marketing: The Wisdom of the Crowd<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn103-article04.htm\">The Socialisation of the Internet is Bogus<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn84-article03.htm\">Socially Challenged Pharma<\/a>: How Ready is Pharma to Engage In Social Media?&gt; <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn49-article03.html\">Society of Industry Leaders: Help for Investors<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_97_UpFront.pdf\">Up Front: Solving the Adherence Problem in Economic Hard Times<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn93-article04.htm\">Solving the Social Media Adverse Event Reporting Problem<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn112-article03.htm\">Some Unregulated Physician Smartphone Apps May Be Buggy<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1304-article02.htm\">The Sorry State of Pharma Mobile Health Apps<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn31-oped.html\">Spam spam spam spam. Lovely spam! Wonderful spam!<\/a>          <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1203-article02.htm\">Spending on Direct-to-Consumer Advertising Takes a Nosedive<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1017-article01.htm\">Stakeholder Effectiveness<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn102-article01.htm\">Strategies for Marketing Compliance<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn78-article04.htm\">The State of CME in Europe<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn67-article02.htm\">Stop Wasting $Millions on Ineffective DTC Ads!<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn44-article05.html\">Straight-Talking DTC Survey Results<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-article05.html\">A Strategic Approach to CME Offers High Return on Education Investment<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn39-article03.html\">Strategies for Enhanced Physician Targeting and Segmentation<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn31-article04.html\">Strategies for Overcoming the Internal Challenges between Rx and OTC<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn32-article04.html\">Super Bowl DTC Debut: Was It Good for You?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn116-article03.htm\">Supporting Patients via Twitter and Beyond<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn62-article02.html\">Surfing the eMarketing Big One!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn49-oped.html\">Surveys Say&#8230;<\/a>    <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn68-article01.htm\">Surviving the Election Wars<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/Article-Upfront-PMN83-Mar09.pdf\">Up Front: Syndication is da Bomb!<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>T&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn210-article03.html\">Tailoring CRM Solutions to Your Business Strategy<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn67-article04a.htm\">A Tale of Two Pharma Whistleblower Novels<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn64-article02.htm\">Targeted Faith-based Disease Awareness Marketing<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn37-article03.html\">The Targeted Model: The Future of Pharmaceutical Marketing?<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn510-article04.html\">Teaching New Dogs Old Tricks<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn19-article02.html\">Texas Medical Privacy Act: A Wolf in Sheep&#8217;s Clothing?<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn45-article02.html\">Thought-Leader Management: A Challenge Met<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn42-oped.html\">Times They Are A-Changing?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn73-article02.htm\">Tips for Improving Pharma Sales<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn47-article01.html\">To Ban or Not to Ban DTC, That is the Question<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-article04.html\">To Build Patient Adherence, Pfizer Puts Technology Behind The Curtain<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn21-article01.html\">Top Companies, Classes, and Products in the DTC Space<\/a>         <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1205-article02.htm\">Toward Patient-Centric Marketing &#8212; Working Effectively with Patient Groups<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1012-article04.htm\">Tracking Public Health Trends: Twitter vs Google vs Your Nose<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn310-article01.html\">The Truth About the Drug Companies: What To Do About It<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn47-article03.html\">Translate Industry Trends into the Optimal Promotional Strategy<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn46-oped.html\">Transparency is the Word These Days<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn56-article01.html\">Trends in Commercial Support of CME<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn411-oped.html\">&#8220;Tribal Marketing&#8221;<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn78-article05.htm\">Turning Science into Sales<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1502-article01.htm\">TV DTC Advertising Is Not Dead Yet!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1011-article05.htm\">The Twelve Steps of Pharma Social Marketers Anonymous<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1501-article01.htm\">2015 Was a Golden Year for Pharma<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1501-article02.htm\">2016 New Year&#8217;s Resolutions for Pharma<\/a><\/li>\n<p\/> <\/ul>\n<p><b>U&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn27-article03.html\">Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn26-article03.html\">Understanding the Proposed ACCME Standards for Commercial Support<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn72-article03.htm\">Understanding the Strategic Value of MSLs<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn113-article03.htm\">US Drug Shortage &amp; Supply Chain Crisis<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn92-article04.htm\">Use of Behavioral Targeting by Pharma Marketers<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn71-article01.htm\">Use of Celebrities for PR and DTC Advertising<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn94-article04.htm\">Use of Social Media for Health Purposes in the EU<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn92-article01.htm\">Use of Twitter for Patient Support<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>V&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn76-article04.htm\">Value-based Pricing<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1013-article05.htm\">Vast Majority of Drug Ads in Leading Medical Journals Don&#8217;t Pass MDs&#8217; Sniff Test!<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn82-article01.htm\">The View From ePharma Summit: Practicing What Was Being Preached!<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn39-oped.html\">Vioxx Withdrawal and the &#8220;Me-Too Drug Domino Effect&#8221;<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1303-article03.htm\">The Virtual Sales Rep<\/a><\/li>\n<p\/> <\/ul>\n<p><b>W&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_92_UpFront.pdf\">Waiting for Goduidance<\/a> (pdf) <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn87-article03.htm\">Waning Pharma Support of CME<\/a>: The Plight of For-Profit MECCs <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-oped.html\">Want to Know What Really Sucks?<\/a>            <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1405-article01.htm\">Wearables, Ingestibles, Implantables<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn41-article06.html\">A Web-based Therapy Management Program<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn68-article02.htm\">Web 2.0 Pharma Marketing Tricks for Dummies<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn73-article03.htm\">What Americans Think About Drug Advertising<\/a>        <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1205-article03.htm\">What Do Physicians Think About DTC, ePromotion, and Social Media?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn88-article01.htm\">What If There Were No Rules in Pharma Marketing?<\/a>    <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn52-article02.html\">What Pharma Companies Spend on Gifts to Docs<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn18-oped.html\">What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn28-article01.html\">What the Next Generation Physician Wants from Pharma<\/a>             <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn31-article01.html\">What You Need to Know About the New &#8220;CAN-SPAM&#8221; Law<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_810_UpFront.pdf\">What&#8217;s Next from the FDA?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn62-article04.html\">What&#8217;s Next vs. What&#8217;s Best<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn114-article01.htm\">What&#8217;s Your Infographics Strategy?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_94_UpFront.pdf\">What&#8217;s Your Social Media Implementation Plan?<\/a>   <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn34-article03.html\">When Is Commercial Support Appropriate for CME Activities?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn77-Sept08-upfront.htm\">Who&#8217;s Better for Pharma: Obama or McCain?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn118-article04.htm\">Who Owns Your Social Media?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn56-article04.html\">Whose Data Is It Anyway?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn29-article01.html\">Why Pharma Can&#8217;t Ignore eDetailers<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn76-article01.htm\">Why Pharmaceutical Marketers Ignore ROI<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn310-article05.html\">Will COX-2 Inhibitors Crash and Burn?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_104_Upfront.pdf\">Will Critics Kill Pharma&#8217;s Social Media Golden Egg Laying Goose?<\/a> (pdf)        <\/li>\n<li><a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn1202-article02.htm\">Will Ethics Revive (Exhume?) the Drug Industry&#8217;s Reputation?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn83-article02.htm\">Will Healthcare be Rationed or Rational?: A Case for Supporting Comparative Effectiveness Research<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_85_UpFront.pdf\">Will the Drug Industry be the Next Auto Industry?<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn71-article03.htm\">Whither CME?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/PMNews_86_UpFront.pdf\">Whither Twitter for Pharma?<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1016-article05.htm\">Without Free Gifts from Pharma to Docs, Would Research be Useless?<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn51-article04.html\">Women in Pharma<\/a>  <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn61-oped.html\">Word-of-Net<\/a>\n<p\/><\/li>\n<\/ul>\n<p><b>Y&#8230;<\/b> <\/p>\n<ul>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1301-article01.htm\">The Year 2013 in Images<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1401-article01.htm\">The Year 2014 in Images<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1407-article03.htm\">The Year 2015 in Images<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn42-article01.html\">You May Walk Like a Duck and Quack Like a Duck, But You&#8217;re No Duck!<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn64-article04.htm\">YouPharma: New Rules for Pharma Marketing and Social Media<\/a> <\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn33-article05.html\">Your Pharma Marketing Sucks<\/a><\/li>\n<li><a href=\"http:\/\/www.news.pharma-mkting.com\/pmn1310-article02.htm\">Your Spouse May Influence Your DTC Viewing Experience<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.<\/p>\n","protected":false},"author":2,"featured_media":14051,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6,9],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma Marketing News - Reprints by Title - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Marketing News - Reprints by Title - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-26T03:32:03+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/Reprints-Featured-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"744\" \/>\n\t<meta property=\"og:image:height\" content=\"487\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"20 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/\",\"name\":\"Pharma Marketing News - Reprints by Title - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2014-01-01T00:00:00+00:00\",\"dateModified\":\"2019-02-26T03:32:03+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Marketing News &#8211; Reprints by Title\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Marketing News - Reprints by Title - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Marketing News - Reprints by Title - Pharma Marketing Network","og_description":"Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/","og_site_name":"Pharma Marketing Network","article_published_time":"2014-01-01T00:00:00+00:00","article_modified_time":"2019-02-26T03:32:03+00:00","og_image":[{"width":744,"height":487,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/Reprints-Featured-Image.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"20 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/","name":"Pharma Marketing News - Reprints by Title - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2014-01-01T00:00:00+00:00","dateModified":"2019-02-26T03:32:03+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/pmn-reprints-by-title\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"Pharma Marketing News &#8211; Reprints by Title"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/12791"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=12791"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/12791\/revisions"}],"predecessor-version":[{"id":12925,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/12791\/revisions\/12925"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/14051"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=12791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=12791"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=12791"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=12791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}